Citigroup
AGTC

Citigroup’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Citigroup’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-450
Closed – – 6858
2022
Q1 		$0 Buy
+450
New +$818 ﹤0.01% 6807
2021
Q3 		– Sell
-400
Closed -$2K – 6473
2021
Q2 		$2K Sell
400
-2,836
-88% -$11.8K ﹤0.01% 6007
2021
Q1 		$16K Sell
3,236
-1,569
-33% -$8.14K ﹤0.01% 5384
2020
Q4 		$20K Buy
4,805
+3,636
+311% +$17.9K ﹤0.01% 6663
2020
Q3 		$6K Sell
1,169
-1,968
-63% -$10.7K ﹤0.01% 6953
2020
Q2 		$17K Buy
+3,137
New +$14.4K ﹤0.01% 6755
2017
Q2 		– Sell
-2,091
Closed -$14K – 7540
2017
Q1 		$14K Sell
2,091
-10,693
-84% -$83.5K ﹤0.01% 6439
2016
Q4 		$119K Buy
12,784
+1,901
+17% +$17.1K ﹤0.01% 5668
2016
Q3 		$106K Sell
10,883
-1,877
-15% -$25.3K ﹤0.01% 5166
2016
Q2 		$180K Sell
12,760
-4,185
-25% -$65.3K ﹤0.01% 4595
2016
Q1 		$237K Buy
16,945
+2,546
+18% +$37.3K ﹤0.01% 4925
2015
Q4 		$294K Buy
14,399
+6,748
+88% +$104K ﹤0.01% 4377
2015
Q3 		$101K Buy
7,651
+2,922
+62% +$48.5K ﹤0.01% 4982
2015
Q2 		$73K Buy
4,729
+4,306
+1,018% +$82.6K ﹤0.01% 5248
2015
Q1 		$9K Sell
423
-571
-57% -$12.8K ﹤0.01% 6514
2014
Q4 		$21K Sell
994
-35,429
-97% -$721K ﹤0.01% 6196
2014
Q3 		$678K Buy
36,423
+36,382
+88,737% +$659K ﹤0.01% 3304
2014
Q2 		$1K Buy
+41
New +$722 ﹤0.01% 6989

Other funds holding AGTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citigroup's AGTC Position: Q2 2022 in Review

Citigroup sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2022, closing a stake of 450 shares.

Citigroup first reported a position in AGTC in Q2 2014 and held it in 18 quarters. The position peaked at $678K in Q3 2014. 47 funds tracked by Wall St. Rank hold AGTC as of Q2 2022.

  • Citigroup reported no remaining Applied Genetic Technologies Corporation position as of Q2 2022 after selling out during the quarter.
  • Citigroup sold 450 Applied Genetic Technologies Corporation shares in Q2 2022.
  • Citigroup first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 18 quarters.
  • Citigroup's Applied Genetic Technologies Corporation position peaked at $678K in Q3 2014.
  • 47 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2022.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.